• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 3D 打印技术构建核壳型多功能药物平台改善胃肠道微生物健康

A core-shell multi-drug platform to improve gastrointestinal tract microbial health using 3D printing.

机构信息

Department of Biomedical Engineering, Key Laboratory of Ministry of Education, Zhejiang University, Hangzhou 310027, People's Republic of China. Zhejiang Provincial Key Laboratory of Cardio-Cerebral Vascular Detection Technology and Medicinal Effectiveness Appraisal, Zhejiang University, Hangzhou 310027, People's Republic of China.

出版信息

Biofabrication. 2020 Mar 13;12(2):025026. doi: 10.1088/1758-5090/ab782c.

DOI:10.1088/1758-5090/ab782c
PMID:32084012
Abstract

Improving the proliferation of probiotics (ca. Bifidobacterium) and inhibiting the growth of pathogenic bacteria (ca. Escherichia coli) is crucial for human health. This study demonstrates the fabrication of core-shell structure fibers using electrohydrodynamic 3D printing to help improve gastrointestinal tract microbial content. These fibers have various geometries and are capable of encapsulating stachyose into cellulose acetate (shell layer) and loading proteoglycan into polyacrylic resin II (core layer). The impact of membrane geometry on drug release behavior and the effect of exchanging the loading site on physicochemical properties of the resulting fibers were studied. The printed fibrous membranes possess a biphasic drug release profile in simulated intestinal fluid with a burst release within the first 12 h and a slower sustained release up to 72 h. The speed order priority for drug release rate of the printed membrane was whole-circle > semi-circle > square. Moreover, the membranes exhibit good biocompatibility on L929 cells and excellent improvement effects on Bifidobacterium bifidum, combining inhibition effects on Escherichia coli. In summary, the dual-drug fibrous membranes presented here and their precision-fabricated patterns pave a new direction for improving the gastrointestinal tract microbial ecosystem health in the human body.

摘要

提高益生菌(双歧杆菌属)的增殖和抑制致病菌(大肠杆菌属)的生长对人类健康至关重要。本研究展示了使用静电纺丝 3D 打印来制造核壳结构纤维,以帮助改善胃肠道微生物含量。这些纤维具有各种几何形状,能够将棉子糖包封在醋酸纤维素(壳层)中,并将糖胺聚糖加载到聚丙烯酸树脂 II(芯层)中。研究了膜几何形状对药物释放行为的影响以及交换加载位置对所得纤维理化性质的影响。打印的纤维膜在模拟肠液中具有双相药物释放曲线,在前 12 小时内有突释,随后缓慢持续释放长达 72 小时。打印膜的药物释放速率的速度优先顺序为整圆>半圆>正方形。此外,这些膜在 L929 细胞上表现出良好的生物相容性,并对双歧杆菌有很好的改善效果,同时抑制大肠杆菌。总之,本文提出的双药物纤维膜及其精密制造的图案为改善人体胃肠道微生物生态系统健康开辟了新的方向。

相似文献

1
A core-shell multi-drug platform to improve gastrointestinal tract microbial health using 3D printing.利用 3D 打印技术构建核壳型多功能药物平台改善胃肠道微生物健康
Biofabrication. 2020 Mar 13;12(2):025026. doi: 10.1088/1758-5090/ab782c.
2
Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption.HPMC 多用途长丝,用于 3D 打印可定制药物释放和定时吸收的药物。
Int J Pharm. 2018 Jun 10;544(1):285-296. doi: 10.1016/j.ijpharm.2018.04.010. Epub 2018 Apr 20.
3
In-vitro GIT Tolerance of Microencapsulated Bifidobacterium bifidum ATCC 35914 Using Polysaccharide-Protein Matrix.体外 GIT 耐受性的微胶囊化双歧杆菌 ATCC 35914 使用多糖-蛋白基质。
Probiotics Antimicrob Proteins. 2019 Sep;11(3):830-839. doi: 10.1007/s12602-017-9384-5.
4
Nanosized sustained-release drug depots fabricated using modified tri-axial electrospinning.采用改良的三轴静电纺丝法制备的纳米级缓释药物贮库。
Acta Biomater. 2017 Apr 15;53:233-241. doi: 10.1016/j.actbio.2017.01.069. Epub 2017 Jan 27.
5
Precision Printing of Customized Cylindrical Capsules with Multifunctional Layers for Oral Drug Delivery.定制圆柱形胶囊的高精度印刷:用于口服给药的多功能层。
ACS Appl Mater Interfaces. 2019 Oct 23;11(42):39179-39191. doi: 10.1021/acsami.9b13568. Epub 2019 Oct 9.
6
Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.制备用于控制药物释放的渗透 3D 打印固体剂型。
Eur J Pharm Sci. 2020 Feb 15;143:105176. doi: 10.1016/j.ejps.2019.105176. Epub 2019 Dec 4.
7
A laminated polymer film formulation for enteric delivery of live vaccine and probiotic bacteria.一种用于活疫苗和益生菌肠溶递送的层压聚合物薄膜制剂。
J Pharm Sci. 2014 Jul;103(7):2022-2032. doi: 10.1002/jps.23997. Epub 2014 May 6.
8
Electrospun thymol-loaded porous cellulose acetate fibers with potential biomedical applications.载有百里香酚的多孔醋酸纤维素纤维的静电纺丝及其在生物医学中的潜在应用。
Mater Sci Eng C Mater Biol Appl. 2020 Apr;109:110536. doi: 10.1016/j.msec.2019.110536. Epub 2019 Dec 9.
9
Three-dimensional printing of shape memory hydrogels with internal structure for drug delivery.具有内部结构的形状记忆水凝胶的三维打印用于药物输送。
Mater Sci Eng C Mater Biol Appl. 2018 Mar 1;84:44-51. doi: 10.1016/j.msec.2017.11.025. Epub 2017 Nov 23.
10
Immunology and probiotic impact of the newborn and young children intestinal microflora.新生儿和幼儿肠道微生物菌群的免疫学和益生菌影响。
Anaerobe. 2011 Dec;17(6):369-74. doi: 10.1016/j.anaerobe.2011.03.010. Epub 2011 Apr 16.

引用本文的文献

1
A Refined Hot Melt Printing Technique with Real-Time CT Imaging Capability.一种具有实时CT成像能力的精细热熔印刷技术。
Micromachines (Basel). 2022 Oct 21;13(10):1794. doi: 10.3390/mi13101794.
2
High Precision 3D Printing for Micro to Nano Scale Biomedical and Electronic Devices.用于微米至纳米级生物医学和电子设备的高精度3D打印
Micromachines (Basel). 2022 Apr 18;13(4):642. doi: 10.3390/mi13040642.
3
Microfluidics-enabled functional 3D printing.基于微流控技术的功能性3D打印
Biomicrofluidics. 2022 Mar 3;16(2):021501. doi: 10.1063/5.0083673. eCollection 2022 Mar.
4
Polysaccharide 3D Printing for Drug Delivery Applications.用于药物递送应用的多糖3D打印
Pharmaceutics. 2022 Jan 7;14(1):145. doi: 10.3390/pharmaceutics14010145.
5
Opportunities and challenges of three-dimensional printing technology in pharmaceutical formulation development.三维打印技术在药物制剂研发中的机遇与挑战
Acta Pharm Sin B. 2021 Aug;11(8):2488-2504. doi: 10.1016/j.apsb.2021.03.015. Epub 2021 Mar 12.
6
Perspectives on Existing and Novel Alternative Intravaginal Probiotic Delivery Methods in the Context of Bacterial Vaginosis Infection.细菌性阴道病感染背景下现有和新型阴道益生菌替代传递方法的观点。
AAPS J. 2021 May 10;23(3):66. doi: 10.1208/s12248-021-00602-z.